Skip to main content

Table 1 Characteristics of the study population at baseline

From: Health-related quality of life associates with change in FEV1 in COPD: results from the COSYCONET cohort

  

Total sample

GOLD 1/2

GOLD 3/4

 

n

 

1734

943

791

p-value1

Male

 

1054 (60.8)

570 (60.5)

484 (61.2)

0.7523

Age, yrs

 

64.6 ± 8.2

65.5 ± 8.3

63.6 ± 8.0

<.0001

Age category

<  55

203 (11.7)

96 (10.2)

107 (13.5)

<.0001

 

55–64

610 (35.2)

300 (31.8)

310 (39.2)

 
 

65–74

750 (43.3)

432 (45.8)

318 (40.2)

 
 

> = 75

171 (9.9)

115 (12.2)

56 (7.1)

 

BMI category2

Normal

648 (37.4)

319 (33.8)

329 (41.6)

<.0001

 

Overweight

642 (37.0)

366 (38.8)

276 (34.9)

 
 

Obese

392 (22.6)

242 (25.7)

150 (19.0)

 
 

Underweight

52 (3.0)

16 (1.7)

36 (4.6)

 

FEV1 (liters)

 

1.61 ± 0.64

2.00 ± 0.56

1.13 ± 0.33

<.0001

FEV1% predicted

 

54.1 ± 18.4

69.6 ± 12.8

38.0 ± 8.2

<.0001

Education

Primary

939 (54.2)

480 (50.9)

459 (58.0)

0.0017

 

Secondary

487 (28.1)

270 (28.6)

217 (27.4)

 
 

Higher

308 (17.8)

193 (20.5)

115 (14.5)

 

Smoking status

Never smoker

124 (7.2)

73 (7.7)

51 (6.5)

<.0001

 

Current smoker

403 (23.2)

258 (27.4)

145 (18.3)

 
 

Former smoker

1207 (69.6)

612 (64.9)

595 (75.2)

 

Comorbidities

Mean number

3.8 (2.6)

3.9 ± 2.6

3.6 ± 2.5

0.0171

Exacerbation history3

none

806 (46.5)

519 (55.0)

287 (36.3)

<.0001

 

mild

86 (5.0)

57 (6.0)

29 (3.7)

 
 

moderate

529 (30.5)

266 (28.2)

263 (33.3)

 
 

severe

313 (18.1)

101 (10.7)

212 (26.8)

 

HRQL measures

SGRQ total score

41.6 ± 19.3

35.5 ± 18.5

48.8 ± 17.7

<.0001

 

Activity component

56.2 ± 25.5

46.6 ± 24.3

67.6 ± 21.9

<.0001

 

Symptoms component

54.4 ± 21.1

50.4 ± 21.6

59.1 ± 19.6

<.0001

 

Impacts component

28.6 ± 19.8

23.8 ± 18.7

34.2 ± 19.4

<.0001

 

EQ VAS

57.7 ± 19.6

62.9 ± 18.6

51.6 ± 19.0

<.0001

  1. Data are presented as mean ± SD or n (%)
  2. 1p-values based on Chi-square-Tests and ANOVA
  3. 2BMI groups were defined as normal weight (18.5 ≤ BMI < 25), overweight (25 ≤ BMI < 30), obese (BMI ≥ 30), and underweight (BMI < 18.5)
  4. 3previous 12 months before examination
  5. BMI Body mass index; FEV1 forced expiratory volume in 1 s; HRQL Health-related quality of life; SGRQ Saint George’s Respiratory Questionnaire; EQ VAS Visual Analog Scale